Project Grant R01MH139865
Award Date
5/1/25
Completion Date
2/28/30
Dollars Obligated
$593K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
This federal Project Grant award, with ID R00MH129611, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The purpose of this $249,000 grant, with a period of performance from September 1, 2024 to August 31, 2027, is to elucidate the neurobiological, genetic, and environmental factors that determine vulnerability or resilience to depression in children at high family risk. The research will examine whether findings from...
This $2,220,017.04 federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, supports a large-scale, single-cell characterization of the molecular and cellular networks underlying mood regulation circuitry in major depressive disorder (MDD). The key objectives are to: 1) identify transcriptomic changes associated with MDD at the single-cell level across 800 human post-mortem brain samples from the anterior...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program provides $535,153 to conduct a large-scale, single-cell characterization of molecular and cellular networks regulating mood in major depressive disorder (MDD). The project aims to generate single-cell transcriptomic profiles to study molecular changes associated with MDD in the anterior cingulate cortex, basolateral amygdala, and hippocampus of 800 human...
The National Institute of Mental Health (NIMH) awarded a $1,413,000 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Arizona State University (ASU) to test the Genetics, Epigenetics, Adverse Childhood Experiences, and Neurobiology (GEAN) Model of Mental Health. This multidisciplinary study aims to identify biomarker clusters and understand the relationship between adverse childhood experiences, genetic and epigenetic factors, and symptoms of stress-related...
This $792,441 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a study investigating the dynamic neural and physiological stress responses of female adolescents at high and low familial risk for depression. The study aims to track changes in default mode network and central executive network connectivity, along with psychophysiological markers like heart rate, heart rate variability, skin...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under CFDA Program 93.242 "Mental Health Research Grants" provides $3,392,617.00 to the Rector & Visitors of the University of Virginia to develop a portable, low-cost, point-of-care microfluidic system for rapid pharmacogenomic screening of patients with major depressive disorder (MDD). The proposed system will enable physicians to quickly determine a patient's metabolizer status for selective...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $1,995,095 to Yale University to conduct research on expanding the genetic understanding of major depressive disorder (MDD) and anxiety disorders (ANX). The 5-year project aims to leverage the large, diverse Veteran Affairs Million Veteran Program (MVP) dataset to identify genetic risk loci for MDD, ANX, and related traits, investigate medication...
This $392,500 federal Project Grant award was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to the University of California, Irvine. The grant supports a 5-year research project from January 1, 2025 to December 31, 2029 to study the developmental origins of mental illness, with a focus on understanding how early life adversity impacts the structure and function of the hypothalamus and its contribution to maladaptive...
The National Institute of Mental Health (NIMH) awarded a $129,288 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop statistical methods and analytical resources for fine-mapping genetic variants associated with psychiatric disorders. The key products and services to be delivered under this 2-year grant (8/1/2024 - 7/31/2026) include: 1) developing a local-ancestry-aware...
The National Institute of Mental Health (NIMH) awarded a $833,123 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Cedars-Sinai Medical Center in West Hollywood, CA. The project, titled "SARS-COV-2 AND SOCIAL DETERMINANTS OF HEALTH IMPACT ON INFLAMMATION ASSOCIATED DEPRESSION RISK (SSIDR)," aims to provide a comprehensive understanding of how SARS-CoV-2 infection and social determinants of health moderate the development of depression through changes in...